Book contents
- Part 1 MRCOG Synoptic Revision Guide
- Part 1 MRCOG Synoptic Revision Guide
- Copyright page
- Contents
- Contributors
- Chapter 1 Physiology of Pregnancy and Labour
- Chapter 2 Fetal Physiology
- Chapter 3 Acid-Base Balance
- Chapter 4 Female Reproductive Physiology
- Chapter 5 Male Reproductive Physiology
- Chapter 6 The Pituitary, Adrenal, Thyroid and Pancreas
- Chapter 7 Congenital Infections
- Chapter 8 Data Interpretation in Obstetrics
- Chapter 9 Clinical Management in Obstetrics
- Chapter 10 Concise Anatomy of the Urinary, Intestinal and Reproductive Tracts within the Pelvic Cavity
- Chapter 11 Concise Anatomy of the Pelvic Floor and Perineum
- Chapter 12 Concise Anatomy of the Pelvic Girdle
- Chapter 13 Concise Anatomy of the Abdominal Walls
- Chapter 14 Early Embryonic Development
- Chapter 15 Development of the Gastrointestinal and Urogenital Tracts
- Chapter 16 Problems in Early Pregnancy
- Chapter 17 Human Immunodeficiency Virus and Other Sexually Transmitted Infections
- Chapter 18 Pharmacokinetics, Pharmacodynamics and Teratogenesis
- Chapter 19 Non-hormonal Therapy in Obstetrics and Gynaecology
- Chapter 20 Drugs in Gynaecology and Contraception
- Chapter 21 Surgical Site Surveillance
- Chapter 22 Data Interpretation in Gynaecology
- Chapter 23 Clinical Management in Gynaecology
- Chapter 24 Carbohydrate Metabolism
- Chapter 25 Fat Metabolism
- Chapter 26 Steroid Hormones and Prostaglandins
- Chapter 27 Calcium Homeostasis and Bone Health
- Chapter 28 Cell Structure and Function
- Chapter 29 Cellular Responses in Disease
- Chapter 30 Pathology of Non-neoplastic and Neoplastic Gynaecological Diseases
- Chapter 31 Implantation and Placental Structure and Function
- Chapter 32 Basic and Reproductive Immunology
- Chapter 33 Molecular Biology
- Chapter 34 Single-Gene and Chromosome Abnormalities
- Chapter 35 Genetic Screening and Diagnosis
- Chapter 36 Biophysics
- Chapter 37 Statistics
- Chapter 38 Clinical Trials, Audit and Meta-analysis
- Appendix: Answers to SBA Questions
- Index
- References
Chapter 20 - Drugs in Gynaecology and Contraception
Published online by Cambridge University Press: 27 July 2023
- Part 1 MRCOG Synoptic Revision Guide
- Part 1 MRCOG Synoptic Revision Guide
- Copyright page
- Contents
- Contributors
- Chapter 1 Physiology of Pregnancy and Labour
- Chapter 2 Fetal Physiology
- Chapter 3 Acid-Base Balance
- Chapter 4 Female Reproductive Physiology
- Chapter 5 Male Reproductive Physiology
- Chapter 6 The Pituitary, Adrenal, Thyroid and Pancreas
- Chapter 7 Congenital Infections
- Chapter 8 Data Interpretation in Obstetrics
- Chapter 9 Clinical Management in Obstetrics
- Chapter 10 Concise Anatomy of the Urinary, Intestinal and Reproductive Tracts within the Pelvic Cavity
- Chapter 11 Concise Anatomy of the Pelvic Floor and Perineum
- Chapter 12 Concise Anatomy of the Pelvic Girdle
- Chapter 13 Concise Anatomy of the Abdominal Walls
- Chapter 14 Early Embryonic Development
- Chapter 15 Development of the Gastrointestinal and Urogenital Tracts
- Chapter 16 Problems in Early Pregnancy
- Chapter 17 Human Immunodeficiency Virus and Other Sexually Transmitted Infections
- Chapter 18 Pharmacokinetics, Pharmacodynamics and Teratogenesis
- Chapter 19 Non-hormonal Therapy in Obstetrics and Gynaecology
- Chapter 20 Drugs in Gynaecology and Contraception
- Chapter 21 Surgical Site Surveillance
- Chapter 22 Data Interpretation in Gynaecology
- Chapter 23 Clinical Management in Gynaecology
- Chapter 24 Carbohydrate Metabolism
- Chapter 25 Fat Metabolism
- Chapter 26 Steroid Hormones and Prostaglandins
- Chapter 27 Calcium Homeostasis and Bone Health
- Chapter 28 Cell Structure and Function
- Chapter 29 Cellular Responses in Disease
- Chapter 30 Pathology of Non-neoplastic and Neoplastic Gynaecological Diseases
- Chapter 31 Implantation and Placental Structure and Function
- Chapter 32 Basic and Reproductive Immunology
- Chapter 33 Molecular Biology
- Chapter 34 Single-Gene and Chromosome Abnormalities
- Chapter 35 Genetic Screening and Diagnosis
- Chapter 36 Biophysics
- Chapter 37 Statistics
- Chapter 38 Clinical Trials, Audit and Meta-analysis
- Appendix: Answers to SBA Questions
- Index
- References
Summary
In low dose, oestrogen (together with a progestogen in women with a uterus) is appropriate for alleviating menopausal symptoms such as vaginal atrophy or vasomotor instability. Oestrogen given systemically in the perimenopausal and postmenopausal period, or tibolone given in the postmenopausal period, also diminish postmenopausal osteoporosis. Hormone replacement therapy (HRT) can be used in women with early natural or surgical menopause (before age 45 years), since they are at high risk of osteoporosis. For early menopause, HRT can be given until the approximate age of natural menopause (i.e. until age 50 years). Alternatives to HRT should be considered if osteoporosis is the main concern.
- Type
- Chapter
- Information
- Part 1 MRCOG Synoptic Revision Guide , pp. 186 - 209Publisher: Cambridge University PressPrint publication year: 2023